Breaking News

US Department of Labor recovers $181K in back wages for Birmingham workers after investigation finds improper claim of overtime pay exemption Laredo Field Office Encourages Online Travel Permits, Consulting Border Wait Times as Summer Travel Begins NVIDIA Announces Financial Results for First Quarter Fiscal 2023 Governor Cooper Releases a Video on Critical Gun Safety Reforms to Protect Our Communities Carnival Corporation & plc Announces Closing of $1.0 Billion Senior Unsecured Notes due 2030 to Refinance 2023 Maturities General Officer Announcements > U.S. Department of Defense > Release Attorney General James Successfully Defends New York’s Right to Hold Gun Manufacturers Responsible for Gun Violence News Release – Attorney General Moody Announces Multistate Action Against Ford Motor Company Resulting in More Than $19 Million for States
Santa Fe, NM --- Attorney General Balderas today filed a lawsuit in the First Judicial District Court of New Mexico against Gilead Sciences, Inc., Bristol-Myers Squibb, Gilead Sciences, LLC, and Teva Pharmaceuticals USA, Inc., for violating the New Mexico Antitrust Act and New Mexico Unfair Practices Act. The lawsuit stems from the development, marketing, and manufacturing of several antiretroviral medications used in the prevention and treatment of Human Immunodeficiency Virus (“HIV”) – a disease which, if left untreated, destroys the immune system and leads to Acquired Immunodeficiency Syndrome (“AIDS”).  The antiretroviral medications at issue include VIREAD®, TRUVADA®, ATRIPLA®, VEMLIDY®, and DESCOVY®. 

Source link